GITENDRA RAJIYAH, MD

Nuclear medicine studies of heart muscle at rest and with stress and spect

Ultrasound of heart with color-depicted blood flow, rate, direction and valve function

Testing of autonomic (sympathetic) nervous system function

Ultrasound of both sides of head and neck blood flow

Ultrasound of leg arteries or artery grafts

Ultrasound of within the brain blood flow following medication

Complete ultrasound of within the brain blood flow

Ultrasound of within the brain blood flow for blood clots

Test for exercise-induced heart and lung stress

Technetium tc-99m tetrofosmin, diagnostic, per study dose

Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts

Transitional care management services for problem of high complexity

Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician

Transitional care management services for problem of at least moderate complexity

Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

New patient office or other outpatient visit, 60-74 minutes

Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days

New patient office or other outpatient visit, 45-59 minutes

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Established patient office or other outpatient visit, 40-54 minutes

Ultrasound of one arm arteries or artery grafts

Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Established patient office or other outpatient visit, 30-39 minutes

Evaluation of neuropsychological test, first hour

Ultrasound study of arm and leg arteries

Testing of autonomic nervous system function and heart rate response to deep breathing

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

Established patient office or other outpatient visit, 20-29 minutes

Advance care planning, first 30 minutes

Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

Hospital discharge day management, 30 minutes or less

Test to measure expiratory airflow and volume

Test to examine how well the lungs exchange gases

Telephone medical discussion with physician, 11-20 minutes

Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month

Test to determine lung volumes using gas dilution or washout

Influenza vaccine split virus, preservative free

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Management using the results of remote vital sign monitoring per calendar month, first 20 minutes

Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month

Injection of drug or substance under skin or into muscle

Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes

Influenza vaccine, quadrivalent, 0.5 ml dosage

Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days

Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes

Administration of psychological or neuropsychological test by technician, first 30 minutes

Administration of influenza virus vaccine

Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)